Publication: 2495

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
      QxMD      Google Scholar   
Citation:
Blood vol 105 (9) 3420-3427
Year:
2005
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA04457, CA11789, CA02599, CA77406, CA0796, CA47577, CA47555, CA32291, CA41287, CA03927, CA26806, CA35279, CA12046, CA16450, 33601, CA77440, CA04326, CA08025, CA21060, 31946, CA47559, CA47642, CA77658, CA12449, CA37135, 101140, 16058, CA31983, CA31946, CA47545  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
CALGB-9222
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Clinical Observations, Interventions, and Therapeutic Trials